May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Effect of Cotylenin A in Retinoblastoma Cell Lines
Author Affiliations & Notes
  • Y. Kashiwagi, II
    Ophthal & Visual Science, Yamagata Univ Sch of Med, Yamagata, Japan
  • N. Kato
    The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan
  • T. Sassa
    Faculty of Agriculture, Yamagata University, Yamagata, Japan
  • T. Yamamoto
    Ophthal & Visual Science, Yamagata Univ Sch of Med, Yamagata, Japan
  • H. Takamura
    Ophthal & Visual Science, Yamagata Univ Sch of Med, Yamagata, Japan
  • H. Yamashita
    Ophthal & Visual Science, Yamagata Univ Sch of Med, Yamagata, Japan
  • Footnotes
    Commercial Relationships  Y. Kashiwagi, None; N. Kato, None; T. Sassa, None; T. Yamamoto, None; H. Takamura, None; H. Yamashita, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3092. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Kashiwagi, II, N. Kato, T. Sassa, T. Yamamoto, H. Takamura, H. Yamashita; Effect of Cotylenin A in Retinoblastoma Cell Lines. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3092. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinoblastoma (RB) is the most common intraocular malignant tumor of childhood. It is believed RB is derived from retina primordial cells, and the differentiation status is related to the pathological findings. Cotylenin A has a novel fucicoccan-diterpene glycoside with a complexsugar moiet, and to accelerate the differentiation of several types of undifferentiated cells, including some myeloid cell lines. This agent is one of the new type anti-cancer therapeutic agents to accelerate cell differentiation. In this report, we investigated effects of cotylenin A on the differentiation of RB cell line.

Methods: : RB cell line, WERI-Rb-1 (WERI cells) were used. WERI cells were cultured in growth medium, and exposed to Cotylenin A (10ug/ml). The morphological changes and cell viability were observed. The expression pattern at mRNA level of retinal development marker and transcriptional factors (Nrl, Chx10, Rx, PAX6, rhodopsin, IRBP) were investigated using RT-PCR.

Results: : The floating round cell attached the Petri-dish. Among the investigated genes, the expression of PAX6 and rhodopsin genes was induced in WERI cells by Cotylenin A, treatment for 3days. The number of the viable cells decreased significantly.

Conclusions: : Cotylenin A was suggested to accelerate to differentiation of retinoblastoma cells.

Keywords: retinoblastoma • differentiation • gene/expression 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×